REGENERON PHARMACEUTICALS, INC. Gross Profit 2008-2019 | REGN
What is gross profit?
Gross profit can be defined as revenue minus the cost of goods sold, representing the profit a company makes before deducting operating expenses.
What is REGENERON PHARMACEUTICALS, INC.'s current gross profit?
REGENERON PHARMACEUTICALS, INC. (REGN) annual gross profit for 2019 was $6.15B, a 25.40% increase from 2018. REGENERON PHARMACEUTICALS, INC. gross profit for the quarter ending March 31, 2018 was $1.44B.
What was REGENERON PHARMACEUTICALS, INC.'s gross profit in 2018?
REGENERON PHARMACEUTICALS, INC. annual gross profit for 2018 was $4.91B, a 13.43% decline from 2017.
What was REGENERON PHARMACEUTICALS, INC.'s gross profit in 2017?
REGENERON PHARMACEUTICALS, INC. annual gross profit for 2017 was $5.67B, a 21.52% increase from 2016.
What is REGENERON PHARMACEUTICALS, INC.'s 5-year gross profit CAGR?
REGENERON PHARMACEUTICALS, INC. gross profit grew at a compound annual growth rate (CAGR) of 18.00% from FY2014 to FY2019, going from $2.69B to $6.15B over 5 years.
Year-over-year comparison from 10-K annual reports